日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
A.D.A.M. Partners with SOPHiA for Liquid Biopsy Japan
A.D.A.M. Innovations, Japan’s leading private genetic testing company, has partnered with SOPHiA…
Shonan iPark and LabCentral Forge Strategic Partnership to Propel Asian Biotech Startups into U.S. Ecosystem
Shonan iPark, a leading life sciences hub in Japan, has teamed up…
Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan’s Biotech and Tech Industries
In October 2025, Novo Nordisk, a Danish pharma company, announced it will…
UK and Japan Forge Strategic Biotech Alliance to Propel Innovation
The UK BioIndustry Association (BIA) is joining forces with the Japan Bioindustry…
From Genomics to Generative AI: Japan’s Bold Step in Personalized Medicine
The planet can no longer treat all people alike. Universal healthcare system…
Asahi Kasei expands Sonanos with next-gen excipients
Asahi Kasei, a leading healthcare materials provider, is growing its Sonanos™ excipient…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Latest Article
English